See article
“Nikzad says Orthogonal has raised $5.5 million from individual and institutional donors as well as crowdfunding campaigns, but he’s not out to make a lot of money. EI.ventures has a team of patent and IP lawyers filing paperwork to protect their product and process, but Nikzad would rather embrace an open-source model to enable a thousand fungi business models to bloom.”
Explore more company info with a Tree membership
📰 Weekly newsletter about the business of psychedelics
📈 Extended company information (analyst view, fundraising, revenue numbers)
🪄 Priority company page updates